New search | Conferencedetail
Print view
 
 

CAR-TCR Summit Europe 2018

evvnt Platform / evvnt
Conference themes
CAR-TCR Summit Europe is the leading end-to-end summit focused on delivering safe, effective and commercially successful CAR and TCR cell therapies globally.

With the first CAR-T approved and the next poised to receive approval from the FDA and EMA by the end of 2017, CAR-T therapies aren't going anywhere and are set to become mainstream frontline cancer treatments.
Professional congress organizer (PCO)
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/169511-1
Speakers: Jian Irish, SVP, Supply Chain, Kite Pharma, Lothar Germeroth, SVP, Managing Director, Juno Therapeutics, Isaac Ciechanover, CEO, Atara Biotherapeutics, Jens Hasskarl, Senior Director
 

Enquiries and Registration:

http://go.evvnt.com/169511-0
Ms. Shaksita Desai
44 020 314187 00
 
Categories
Oncology
Languages
English
Congress fees
GBP 499,00
(Gold: Conference + 2 Workshops: GBP 2497, Silver: Conference + 1 Workshop: GBP 2098, Bronze: Conference Only: GBP 1699, Workshop Only: GBP 499)
Participants expected
100 - 500
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
Tel: +44 0207 3230 450
hello@evvnt.com
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Helix - Forschung & Beratung WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.Ärzte der WeltnewTreeÖsterreichisches Rotes KreuzÄrztekammer für Wien

Facebook

Give us your professional opinion

Start survey

Start survey